Need DRUG data in your own agent or pipeline?
Every table on this page — income statement, balance sheet, cash flow, PE history, dividends — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.
Financial statements and analysis
Period names from company filings, with term end dates and filing dates
Income Statement (CAD) Term End Date Filing Date | 2025 Sep 30, 2025 Dec 23, 2025 | 2024 Sep 30, 2024 Dec 31, 2024 | 2023 Sep 30, 2023 Dec 29, 2023 | 2022 Sep 30, 2022 Sep 30, 2022 | 2021 Sep 30, 2021 Sep 30, 2021 | 2020 Sep 30, 2020 Sep 30, 2020 | 2019 Sep 30, 2019 Sep 30, 2019 |
|---|
Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Margin % | - | - | - | - | - | - | - |
Research & Development | 11.08M 839.4% | 1.18M 76.4% | 5.00M 59.0% | 12.18M 92.9% | 6.31M 1679.3% | 354.85K 181.6% | 126.03K |
General & Administrative | 2.14M 53.1% | 1.40M 32.9% | 2.08M 4.1% | 2.00M 37.2% | 1.46M 1219.1% | 110.46K 0.3% | 110.12K |
Selling & Marketing | 429.66K 932.8% | 41.60K 65.2% | 119.42K 78.4% | 551.86K 35.2% | 852.15K 8760.0% | 9.62K | 0.00 |
SG&A Expenses | 2.57M 78.6% | 1.44M 34.7% | 2.20M 13.8% | 2.55M 10.5% | 2.31M 1823.1% | 120.07K 9.0% | 110.12K |
Other Operating Expenses | 287.65K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Operating Expenses | 13.94M 432.7% | 2.62M 63.7% | 7.20M 51.1% | 14.73M 70.8% | 8.62M 1715.7% | 474.93K 101.1% | 236.15K |
Cost and Expenses | 13.94M 432.7% | 2.62M 63.7% | 7.20M 51.1% | 14.73M 70.8% | 8.62M 1715.7% | 474.93K 101.1% | 236.15K |
Operating Income | -13.94M 432.7% | -2.62M 63.7% | -7.20M 51.1% | -14.73M 70.8% | -8.62M 1715.7% | -474.93K 101.1% | -236.15K |
Operating Margin % | - | - | - | - | - | - | - |
EBITDA | -12.15M | 0.00 100.0% | -7.28M 51.3% | -14.96M | 0.00 | 0.00 | 0.00 |
EBITDA Margin % | - | - | - | - | - | - | - |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Income | 1.52M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income (Expense) | 1.71M 1021.8% | -185.31K 7.4% | -172.46K 26.0% | -232.93K 742.6% | -27.64K 407.1% | -5.45K | 0.00 |
Pre-Tax Income | -12.23M 336.5% | -2.80M 62.0% | -7.37M 50.7% | -14.96M 73.0% | -8.65M 1700.8% | -480.38K 103.4% | -236.15K |
Pre-Tax Margin % | - | - | - | - | - | - | - |
Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | -12.23M 336.5% | -2.80M 62.0% | -7.37M 50.7% | -14.96M 73.0% | -8.65M 1700.8% | -480.38K 103.4% | -236.15K |
Net Margin % | - | - | - | - | - | - | - |
Basic EPS | -1.78 173.8% | -0.65 67.2% | -1.98 67.8% | -6.15 29.7% | -4.74 1147.4% | -0.38 517.9% | -0.06 |
Diluted EPS | -1.78 173.8% | -0.65 67.2% | -1.98 67.8% | -6.15 29.7% | -4.74 1147.4% | -0.38 533.3% | -0.06 |
Basic Shares Outstanding | 6.88M 59.6% | 4.31M 15.9% | 3.72M 50.5% | 2.47M 37.6% | 1.79M 40.1% | 1.28M 0.0% | 1.28M |
Diluted Shares Outstanding | 6.88M 59.6% | 4.31M 15.9% | 3.72M 50.6% | 2.47M 37.6% | 1.79M 40.1% | 1.28M 0.0% | 1.28M |